The Valley Desk

NCT03288545 · Interventional trial

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Carcinoma, Transitional Cell, Renal Pelvis Neoplasms, Ureteral Neoplasms, Urethral Neoplasms, Urinary Bladder Neoplasms, Urologic Neoplasms, Urothelial Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov